(Q42499848)

1 November 2017

Age-related findings on MRI in neurofibromatosis type 1. (English)

1 reference

1 November 2017

4

1 reference

1 November 2017

Deepak S Gill

1

1 reference

PubMed ID

16912896

1 November 2017

Shelley L Hyman

series ordinal

2

1 reference

PubMed ID

16912896

1 November 2017

Adam Steinberg

series ordinal

3

1 reference

1 November 2017

16 August 2006

1 reference

1 November 2017

1 reference

1 November 2017

36

1 reference

1 November 2017

10

1 reference

1 November 2017

1048-1056

1 reference

https://scigraph.springernature.com/pub.10.1007/s00247-006-0267-2

1 November 2017

0 references

cites work

Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status.

1 reference

https://api.crossref.org/works/10.1007%2FS00247-006-0267-2

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-006-0267-2

Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-006-0267-2

Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-006-0267-2

Malformations of cortical development in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-006-0267-2

Identification and characterization of the neurofibromatosis type 1 protein product

21 January 2018

1 reference

12 December 2020

Neurofibromatosis types 1 and 2: cranial MR findings

1 reference

12 December 2020

Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.

1 reference

12 December 2020

MRI in neurofibromatosis type I: using fluid-attenuated inversion recovery pulse sequences.

1 reference

12 December 2020

Differential regulation of rasGAP and neurofibromatosis gene product activities

1 reference

12 December 2020

Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain

1 reference

12 December 2020

Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

1 reference

12 December 2020

The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect.

1 reference

12 December 2020

Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

1 reference

12 December 2020

The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropathological study of 22 cases.

1 reference

12 December 2020

A mouse model for the learning and memory deficits associated with neurofibromatosis type I

1 reference

12 December 2020

MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment

1 reference

12 December 2020

Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis

1 reference

12 December 2020

Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities

1 reference

12 December 2020

Neurofibromatosis type 1: the cognitive phenotype.

1 reference

12 December 2020

Neurofibromin Expression and Astrogliosis in Neurofibromatosis (Type 1) Brains

1 reference

12 December 2020

Evolution of white matter lesions in neurofibromatosis type 1: MR findings

1 reference

12 December 2020

MRI findings in children with neurofibromatosis type 1: a prospective study.

1 reference

12 December 2020

High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis

1 reference

12 December 2020

The neurofibromatosis type 1 gene encodes a protein related to GAP

1 reference

12 December 2020

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations

1 reference

12 December 2020

Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

1 reference

12 December 2020

Identification of the neurofibromatosis type 1 gene product

1 reference

12 December 2020

10.1007/S00247-006-0267-2

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

16912896